Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

Yan-qi Kou; Yu-ping Yang; Zhao-jie Pan; Shen-shen Du; Wei-nan Yuan; Kun He; Biao Nie

doi:10.12659/MSM.938785

11 March 2023 : Database Analysis

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

Yan-qi Kou^1ACEF, Yu-ping Yang^1BCE, Zhao-jie Pan^2E, Shen-shen Du^1BC, Wei-nan Yuan^1BC, Kun He^1E, Biao Nie^1A*

DOI: 10.12659/MSM.938785

Med Sci Monit 2023; 29:e938785

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Kaplan-Meier (KM) survival curves analysis for hub proteins expression. (A) Based on PLG, COPS5, EPB42, FYN, ITGB3, SLC4A1, IRF3, and SPTA1 expression in PDAC samples, survival curves of the overall survival and (B) recurrence-free survival were constructed using KM plotter (KM plotter, 2022.08.23, https://kmplot.com/analysis/).

Back to the Article

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

Your Privacy